人工电子耳市场:按患者类型、最终用户和地区进行分析和预测(2024 至 2034 年)
市场调查报告书
商品编码
1667209

人工电子耳市场:按患者类型、最终用户和地区进行分析和预测(2024 至 2034 年)

Cochlear Implants Market - A Global and Regional Analysis: Focus on Patient Type, End User, and Region - Analysis and Forecast, 2024-2034

出版日期: | 出版商: BIS Research | 英文 70 Pages | 商品交期: 1-5个工作天内

价格

全球人工电子耳市场规模预计将从 2023 年的 24.244 亿美元成长到 2034 年的 66.399 亿美元,预测期内的复合年增长率为 9.02%。

近年来,人工电子耳市场呈现强劲成长势头,预计仍将继续扩大,儘管成长速度可能因情况而异。人工电子耳是一种电子医疗设备,旨在为无法从传统助听器中受益的中度至重度听力损失患者提供声音感知。这些植入绕过内耳(耳蜗)受损区域并直接刺激听觉神经,使用户能够感知声音并提高对语音的理解。

主要市场统计数据
预测期 2024-2034
2024 年评估 28.2亿美元
2034 年预测 66.399 亿美元
复合年增长率 9.02%

受听力恢復技术的进步和感音性听障盛行率不断上升的推动,全球人工电子耳市场正在经历显着增长。根据世界卫生组织(WHO)发布的资料,全球有超过4.3亿人有听力损失,预计到2050年这数字将达到7亿。此外,人工电子耳技术的进步,包括更有效、更用户友好的基于人工智慧的语音处理、无线连接和 MRI 相容植入,预计将显着改善患者的治疗效果。全球各国政府和医疗保健组织也透过优惠的报销政策和资助计画支持市场,提高儿科和成人患者的治疗可及性。

根据患者类型,成人群体占据市场主导地位:

根据患者类型,成人患者将在 2023 年占据最大份额,预计到 2034 年将达到 42.827 亿美元,预测期内的复合年增长率为 8.55%。与老龄化相关的听力损失的盛行率正在增加,人工电子耳作为治疗方法中度至重度听力损失的有效方法越来越受到广泛认可。随着全球老龄人口的成长,成人对人工人工电子耳的需求大幅成长,尤其是在北美、欧洲等已开发地区。此外,随着植入设计、手术技术和植入后復原的不断创新,成人市场预计将在未来几年内在人工电子耳市场保持主导地位。

根据最终用户,医院部门占据市场主导地位:

根据最终用户,医院部门预计将在 2023 年占据最大份额,预计到 2034 年将达到 41.831 亿美元,预测期内的复合年增长率为 8.71%。主导市场的关键因素是成功移植所需的先进手术基础设施、耳鼻喉设备、熟练的医疗专业人员和术后復健服务。该医院是儿科和成人患者的主要护理点,提供全面的诊断评估、手术植入和长期听力支持。由耳鼻喉科专家、听力学家、语言治疗师和復健专家组成的多学科团队可确保最佳的患者治疗效果,进一步有利于医院内的人工电子耳植入手术。

人工电子耳市场细分

细分一:按患者类型

  • 成人
  • 孩子们

细分 2:按最终用户

  • 医院
  • 耳鼻喉科诊所
  • 其他的

细分 3:按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

本报告调查了全球人工电子耳市场,并总结了主要趋势、影响市场的因素分析、法律制度、市场规模的趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局以及主要企业的概况。

目录

执行摘要

范围和定义

第一章市场:产业展望

  • 趋势:当前和未来的影响评估
  • 供应链分析
  • 监管状态
  • 市场动态概览
    • 影响分析
    • 市场驱动因素
    • 市场限制
    • 市场机会

2. 全球人工电子耳市场依患者类型划分

  • 成人
  • 孩子们

3. 全球人工电子耳市场(以最终用户划分)

  • 医院
  • 耳鼻喉科诊所
  • 其他的

第四章 区域

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第五章市场:竞争基准化分析与公司概况

  • 主要进展
  • 公司简介
    • iotaMotion, Inc.
    • Envoy Medical
    • Amplifon, (GAES)
    • Cochlear Ltd.
    • Sonova Holdings AG
    • MED-EL Medical Electronics
    • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. (Nurotron)

第六章调查方法

Product Code: BHM2572SA

Introduction of Cochlear Implants

The global cochlear implants market, initially valued at $2,424.4 million in 2023, is set to witness substantial growth, projected to surge to $6,639.9 million by 2034, marking a remarkable compound annual growth rate (CAGR) of 9.02% over the period from 2024 to 2034. The cochlear implants market has shown robust growth in recent years and is poised to continue expanding, though the pace may vary under different conditions. Cochlear implants are electronic medical devices designed to provide sound perception to individuals with severe-to-profound hearing loss who do not benefit from conventional hearing aids. These implants directly stimulate the auditory nerve, bypassing damaged parts of the inner ear (cochlea), enabling users to perceive sound and improve speech comprehension.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$2,800.2 Million
2034 Forecast$6,639.9 Million
CAGR9.02%

The global cochlear implants market has been experiencing significant growth, fueled by advancements in hearing restoration technologies and the increasing prevalence of sensorineural hearing loss. According to the data published by the World Health Organization (WHO), over 430 million people worldwide suffer from disabling hearing loss, with this number expected to reach 700 million by 2050. Additionally, advancements in cochlear implant technology, such as AI-based sound processing, wireless connectivity, and MRI-compatible implants, have significantly improved patient outcomes, making these devices more effective and user-friendly. Governments and healthcare organizations worldwide are also supporting the market through favorable reimbursement policies and funding initiatives, increasing accessibility for both pediatric and adult patients.

Industrial Impact

The cochlear implants market has significantly influenced the healthcare landscape, driven by key players such as Cochlear Limited., Sonova Holdings AG, Amplifon, (GAES), and others. These companies have been at the forefront, providing cutting-edge products for cochlear implants.

Moreover, the market has been further shaped by strategic collaborations, mergers, and R&D investments, which enable companies to expand their global presence and introduce innovative solutions. With the increasing focus on understanding tissue architecture and disease mechanisms, the competitive landscape of the cochlear implants market is dynamic, with innovation and customer-centric approaches driving differentiation and growth.

Market Segmentation for Cochlear Implants Market:

Segmentation 1: by Patient Type

  • Adult
  • Pediatric

Adult Segment to Dominate the Cochlear Implants Market (by Patient Type)

Based on patient type, the global cochlear implants market was led by the adult segment, which accounted for the largest share in 2023 and is expected to reach $4,282.7 million by 2034, registering a CAGR of 8.55% during the forecast period 2024-2034. The rising prevalence of age-related hearing loss and increasing awareness of cochlear implantation as an effective treatment for severe-to-profound hearing impairment. With a growing global geriatric population, particularly in developed regions such as North America and Europe, the demand for cochlear implants among adults is increasing significantly. Additionally, with continued innovation in implant design, surgical techniques, and post-implantation rehabilitation, the adult segment is expected to maintain its dominance in the cochlear implant market in the coming years.

Segmentation 2: by End User

  • Hospitals
  • ENT Clinics
  • Others

Hospitals Segment to Dominate the Cochlear Implants Market (by End User)

Based on end user, hospitals accounted for the largest share in 2023 and are expected to reach $4,183.1 million by 2034, registering a CAGR of 8.71% during the forecast period 2024-2034. A key factor contributing to the market's dominance is the availability of advanced surgical infrastructure, ENT devices, skilled healthcare professionals, and post-operative rehabilitation services required for successful implantation. Hospitals serve as the primary point of care for both pediatric and adult patients, offering comprehensive diagnostic assessments, surgical implantation, and long-term audiological support. The presence of multidisciplinary teams, including ENT specialists, audiologists, speech therapists, and rehabilitation experts, ensures optimal patient outcomes, further driving preference for hospital-based cochlear implant procedures.

Segmentation 3: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

In 2023, North America region dominated the global cochlear implants market; however, the Asia-Pacific region is expected to register the highest CAGR of 10.53% during the forecast period 2024-2034. high healthcare expenditure, advanced medical infrastructure, and strong government support for hearing loss treatment are a few factors driving the growth of the region. The increasing awareness about hearing restoration solutions, along with the rising adoption of bilateral cochlear implantation, further supports market growth. Moreover, an aging population and the rising prevalence of age-related hearing loss have fueled demand among older adults seeking cochlear implants to improve their quality of life.

Recent Developments in the Cochlear Implants Market

  • In May 2024, Cochlear Limited completed the acquisition of Oticon Medical's cochlear implant business from Demant, integrating approximately 20,000 Oticon Medical cochlear implant customers into its operations. This strategic move aims to provide continued support and transition these customers to Cochlear's technology platform over time.
  • In March 2023, MED-EL Medical Electronics introduced direct streaming for their cochlear implant patients. This feature, available in their new MED-EL cochlear implant systems, allows users to stream audio directly from compatible devices (such as smartphones) to their implants, improving sound quality and convenience. This innovation enhances accessibility and user experience for individuals with hearing loss.
  • In November 2024, Cochlear Limited launched the Nucleus 8 Sound Processor, featuring enhanced connectivity for direct streaming from Apple and Android devices and improved hearing in noisy environments. This innovation aims to provide clearer sound and greater convenience for individuals with hearing loss.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Rising Prevalence of Hearing Loss: The global prevalence of hearing loss is increasing at an alarming rate, driven by factors such as aging populations, excessive noise exposure, genetic predisposition, and untreated ear infections. According to the World Health Organization (WHO), over 1.5 million people worldwide currently experience some degree of hearing impairment, with this number expected to rise due to demographic and environmental factors. Additionally, increased awareness and early diagnosis are leading to a higher adoption of hearing aids and cochlear implants, addressing the needs of individuals with severe to profound hearing loss.

Market Challenges:

High Cost of Devices and Surgery: Despite the benefits of cochlear implants, their high cost remains a significant barrier limiting market penetration, particularly in low- and middle-income countries. A single cochlear implant procedure (including the device, surgery, and rehabilitation therapy) can cost $50,000 to $100,000 in the U.S., and prices are similarly steep elsewhere. Without insurance or subsidies, this expense is prohibitive for most patients. In developing regions, the lack of affordability is a primary reason that so few people who need implants receive them. Globally, it's estimated that only about 5-10% of candidates who could benefit from a cochlear implant have one, largely due to cost and access issues. The result is a substantial unmet medical need, where millions continue to live with severe hearing loss because the up-front price of treatment is out of reach.

Market Opportunities:

Increasing Adoption in Emerging Markets: Emerging markets present a significant growth opportunity for the cochlear implants market due to improving healthcare infrastructure, rising awareness of hearing loss treatments, and increasing disposable income. Countries in Asia-Pacific, Latin America, and Africa are witnessing a surge in demand for cochlear implants as governments and healthcare organizations work toward expanding access to advanced medical technologies. Additionally, initiatives like subsidized healthcare programs, insurance coverage expansion, and partnerships with global medical device companies are making cochlear implants more affordable and accessible.

How can this report add value to an organization?

Product/Innovation Strategy: The global cochlear implants market has been extensively segmented based on various categories, such as patient type, end user, and region.

Growth/Marketing Strategy: Mergers, acquisitions, and product launches accounted for the maximum number of key developments in the market.

Competitive Strategy: The global cochlear implants market has numerous established players with product portfolios. Key players in the global cochlear implants market analyzed and profiled involve established players offering products for cochlear implants.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2021-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2034.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of the cochlear implants market.
  • The market size was estimated and validated using both bottom-up and top-down analyses. The market size for each type, patient type, and end user was estimated for the bottom-up approach. These were further added to cumulate the market size of the global cochlear implants market.
  • The top-down analysis was conducted to arrive at the market contributions of various segments as defined in the scope.
  • The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year.
  • The market has been mapped based on available cochlear implants. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in cochlear implants, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of the report's segmentation and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of the different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players of the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Cochlear Limited.
  • Sonova Holding AG.
  • Zhejiang Nurotron Biotechnology Co., Ltd. (Nurotron)
  • MED-EL Medical Electronics

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Miniaturization of Sensors and Components in Hearing Implants
  • 1.2 Supply Chain Analysis
  • 1.3 Regulatory Landscape
    • 1.3.1 U.S.
    • 1.3.2 Europe
    • 1.3.3 Asia-Pacific
    • 1.3.4 Rest-of-the-World
  • 1.4 Market Dynamics Overview
    • 1.4.1 Impact Analysis
    • 1.4.2 Market Drivers
      • 1.4.2.1 Rising Prevalence of Hearing Loss
      • 1.4.2.2 Technological Advancements in Cochlear Implants
      • 1.4.2.3 Government Health Initiatives and Favorable Reimbursement
    • 1.4.3 Market Restraints
      • 1.4.3.1 High Cost of Devices and Surgery
      • 1.4.3.2 Low Awareness Related to Cochlear Implants
    • 1.4.4 Market Opportunities
      • 1.4.4.1 Increasing Adoption in Emerging Markets

2 Global Cochlear Implants Market, by Patient Type

  • 2.1 Adults
  • 2.2 Pediatric

3 Global Cochlear Implants Market, by End User

  • 3.1 Hospitals
  • 3.2 ENT Clinics
  • 3.3 Others

4 Regions

  • 4.1 North America
    • 4.1.1 Regional Overview
    • 4.1.2 Driving Factors for Market Growth
    • 4.1.3 Factors Challenging the Market
    • 4.1.4 Market Sizing and Forecast
      • 4.1.4.1 U.S.
      • 4.1.4.2 Canada
  • 4.2 Europe
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Market Sizing and Forecast
      • 4.2.4.1 Germany
      • 4.2.4.2 U.K.
      • 4.2.4.3 France
      • 4.2.4.4 Italy
      • 4.2.4.5 Spain
      • 4.2.4.6 Rest-of-Europe
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Market Sizing and Forecast
      • 4.3.4.1 Japan
      • 4.3.4.2 China
      • 4.3.4.3 India
      • 4.3.4.4 Rest-of-Asia-Pacific
  • 4.4 Latin America
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Market Sizing and Forecast
      • 4.4.4.1 Brazil
      • 4.4.4.2 Mexico
      • 4.4.4.3 Rest-of-Latin America
  • 4.5 Middle East and Africa
    • 4.5.1 Regional Overview
    • 4.5.2 Market Sizing and Forecast

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Key Developments
    • 5.1.1 Key Strategies and Development
  • 5.2 Company Profiles
    • 5.2.1 iotaMotion, Inc.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products/Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers
      • 5.2.1.5 Analyst View
    • 5.2.2 Envoy Medical
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products/Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers
      • 5.2.2.5 Analyst View
    • 5.2.3 Amplifon, (GAES)
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers
      • 5.2.3.5 Analyst View
    • 5.2.4 Cochlear Ltd.
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers
      • 5.2.4.5 Analyst View
    • 5.2.5 Sonova Holdings AG
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products/Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers
      • 5.2.5.5 Analyst View
    • 5.2.6 MED-EL Medical Electronics
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers
      • 5.2.6.5 Analyst View
    • 5.2.7 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. (Nurotron)
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers
      • 5.2.7.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Cochlear Implants Market (by Patient Type), $Million, 2023 and 2034
  • Figure 2: Global Cochlear Implants Market (by End User), $Million, 2023 and 2034
  • Figure 3: Global Cochlear Implant Market (by Region), $Million, 2023, 2027, and 2034
  • Figure 4: Key Events to Keep Track of in the Global Cochlear Implants Market
  • Figure 5: Supply Chain Analysis: Global Cochlear Implants Market
  • Figure 6: Impact Analysis of Cochlear Implants Market Navigating Factors, 2024-2034
  • Figure 7: North America Cochlear Implants Market, $Million, 2023-2034
  • Figure 8: U.S. Cochlear Implants Market, $Million, 2023-2034
  • Figure 9: Canada Cochlear Implants Market, $Million, 2023-2034
  • Figure 10: Europe Cochlear Implants Market, $Million, 2023-2034
  • Figure 11: Germany Cochlear Implants Market, $Million, 2023-2034
  • Figure 12: U.K. Cochlear Implants Market, $Million, 2023-2034
  • Figure 13: France Cochlear Implants Market, $Million, 2023-2034
  • Figure 14: Italy Cochlear Implant Market, $Million, 2023-2034
  • Figure 15: Spain Cochlear Implants Market, $Million, 2023-2034
  • Figure 16: Rest-of-Europe Cochlear Implants Market, $Million, 2023-2034
  • Figure 17: Asia-Pacific Cochlear Implants Market, $Million, 2023-2034
  • Figure 18: Japan Cochlear Implants Market, $Million, 2023-2034
  • Figure 19: China Cochlear Implants Market, $Million, 2023-2034
  • Figure 20: India Cochlear Implants Market, $Million, 2023-2034
  • Figure 21: Rest-of-Asia-Pacific Cochlear Implants Market, $Million, 2023-2034
  • Figure 22: Latin America Cochlear Implants Market, $Million, 2023-2034
  • Figure 23: Brazil Cochlear Implants Market, $Million, 2023-2034
  • Figure 24: Mexico Cochlear Implants Market, $Million, 2023-2034
  • Figure 25: Rest-of-Latin America Cochlear Implants Market, $Million, 2023-2034
  • Figure 26: Middle East and Africa Cochlear Implants Market, $Million, 2023-2034
  • Figure 27: Strategic Initiatives, January 2020-January 2025
  • Figure 28: Data Triangulation
  • Figure 29: Top-Down and Bottom-Up Approach
  • Figure 30: Assumptions and Limitations

List of Tables

  • Table 1: Key Trends, Global Cochlear Implants Market
  • Table 2: Evolution of Component Size in Hearing Implants
  • Table 3: Global Prevalence of Hearing Loss, 2019-2021
  • Table 4: Global Cochlear Implants Market (by Patient Type), $Million, 2023-2034
  • Table 5: Global Cochlear Implants Market (by End User), $Million, 2023-2034
  • Table 6: Global Cochlear Implants Market (by Region), $Million, 2023-2034
  • Table 7: Recent Developments by Companies in the Global Cochlear Implants Market, 2023 and 2024